Dried form of Rasnadi Ksheerapaka versus Shatapushpa Curna in Kastartava (Primary Dysmenorrhea)- Clinical Study

Evaluation of Comparative efficacy of Spray Dried form of Rasnadi Ksheerapaka versus Shatapushpa Curna in Kastartava (Primary Dysmenorrhea)- A Randomized Controlled Study - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062320

Enrollment

164

Registered

2024-02-06

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N70-N77- Inflammatory diseases of female pelvic organs Health Condition 2: N944- Primary dysmenorrhea Health Condition 3: N944- Primary dysmenorrhea

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients within the age group between 14 years to 40 years who are clinically diagnosed with Primary Dysmenorrhea Patients who are giving consent to the study Patients with regular menstrual cycle who are suffering from the past three menstrual cycles

Exclusion criteria

Exclusion criteria: Patients with concomitant genito-urinary infection Patients who were under hormonal therapy Dysmenorrhea secondary to any drug intake, Long standing smoking, other systemic disorders Those who have Perceived Stress Scale 10 greater than 13 Those with Highly sensitive Reactive Protein greater than 3

Design outcomes

Primary

Measure	Time frame
Improvement in severity and duration of pain in Primary Dysmenorrhea by Visual Analogue scale and Cox menstrual Scale respectivelyTimepoint: Severity and duration of pain measured at Baseline, Day 3 of first menstrual Cycle, Day 3 of second menstrual cycle, Day 3 of third menstrual cycle, Day 3 of fourth menstrual cycle, Day 3 of fifth menstrual cycle, Day 3 of sixth menstrual cycle	—

Secondary

Measure	Time frame
Improvement in severity of Primary Dysmenorrhea by Verbal Menstrual Questionnarre Improvement in Quality of Life by Moos Menstrual Distress Questionnarre Improvement in Highly Sensitive Reactive ProteinTimepoint: Severity of Primary Dysmeorrhea will be measured at Baseline, Day 3 of first menstrual cycle, Day 3 of second menstrual cycle, Day 3 of third menstrual cycle, Day 3 of fourth menstrual cycle, Day 3 of fifth menstrual cycle, Day 3 of sixth menstrual cycle. Improvement of Quality of Life will be measured at baseline, Day 3 of 6th menstrual cycle. Improvement of Highly Sensitive Reactive protein at baseline & Day 3 of first menstrual cycle.	—

Measure

Time frame

Improvement in severity of Primary Dysmenorrhea by Verbal Menstrual Questionnarre Improvement in Quality of Life by Moos Menstrual Distress Questionnarre Improvement in Highly Sensitive Reactive ProteinTimepoint: Severity of Primary Dysmeorrhea will be measured at Baseline, Day 3 of first menstrual cycle, Day 3 of second menstrual cycle, Day 3 of third menstrual cycle, Day 3 of fourth menstrual cycle, Day 3 of fifth menstrual cycle, Day 3 of sixth menstrual cycle. Improvement of Quality of Life will be measured at baseline, Day 3 of 6th menstrual cycle. Improvement of Highly Sensitive Reactive protein at baseline & Day 3 of first menstrual cycle.

—

Countries

India

Contacts

Public ContactDr Prathiksha Rathod

MGACH Datta Meghe Institute of Higher Education and Research Wardha

pudgal9@gmail.com9284295220

Outcome results